Shedir Pharma Group
Researches, develops, and commercializes health and wellness products.
SHE | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005379620
- LEI:
- 81560092B300849E9017
- Country:
- Italy
- Address:
- VIA BAGNULO, 95, 80063 PIANO DI SORRENTO
- Sector:
- Manufacturing
Description
Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-29 15:26 |
Assemblea ordinaria e straordinaria degli Azionisti del 29 aprile 2021
|
Italian | 809.1 KB | ||
| 2021-04-28 18:55 |
Certificazione come dispositivi medici di classe IIA per i prodotti della Linea…
|
Italian | 688.5 KB | ||
| 2021-04-14 16:40 |
Avviso di deposito della Relazione Finanziaria Annuale 2020 e della documentazi…
|
Italian | 514.3 KB | ||
| 2021-04-14 11:26 |
Pubblicazione dell’Avviso di Convocazione dell’Assemblea Ordinaria e Straordina…
|
Italian | 259.7 KB | ||
| 2021-03-29 12:49 |
Shedir Pharma Group S.p.A. - Comunicato Stampa Bilancio d'esercizio e consolida…
|
Italian | 736.3 KB | ||
| 2021-01-29 11:43 |
Shedir Pharma Group S.p.A. - Nomina del nuovo Consigliere Esecutivo
|
Italian | 680.5 KB | ||
| 2021-01-29 11:07 |
Shedir Pharma Group - Calendario eventi societari 2021
|
Italian | 613.5 KB | ||
| 2021-01-21 18:40 |
Certificazione come dispositivi medici di classe IIA per i prodotti della Linea…
|
Italian | 686.5 KB | ||
| 2021-01-20 11:24 |
Dimissioni Consigliere Indipendente
|
Italian | 670.2 KB | ||
| 2020-12-21 16:18 |
Nomina nuovo Nominated Adviser (NOMAD)
|
Italian | 678.5 KB | ||
| 2020-12-14 07:02 |
Pubblicazione del Brevetto Pelirgostim® sulla rivista Bioscience Reports e otte…
|
Italian | 722.3 KB | ||
| 2020-09-29 18:50 |
Shedir Pharma Group - Comunicato Stampa_Relazione semestrale consolidata al 30 …
|
Italian | 523.7 KB | ||
| 2020-08-06 18:37 |
Dymalife Pharmaceutical S.r.l. finalizza l’acquisizione di EMINOCS
|
Italian | 319.3 KB | ||
| 2020-06-01 19:25 |
Ridefinizione compensi amministratori esecutivi
|
Italian | 349.5 KB | ||
| 2020-05-14 15:50 |
Verbale Assemblea ordinaria degli azionisti tenutasi il 29.04.2020
|
Italian | 322.8 KB |
Automate Your Workflow. Get a real-time feed of all Shedir Pharma Group filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Shedir Pharma Group
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Shedir Pharma Group via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
